Literature DB >> 30142872

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma: Erratum.

.   

Abstract

Entities:  

Year:  2018        PMID: 30142872      PMCID: PMC6113028          DOI: 10.1097/MD.0000000000012163

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


× No keyword cloud information.
In the article, “Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma”,[ which appeared in Volume 97, Issue 31 of Medicine, the authors would like to add the funding information “This work was supported by Shandong Medicine and Health Science Technology Development Plan 2014WS0288.”
  1 in total

1.  Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma.

Authors:  Haiying Peng; Shaobo Yao; Qingyu Dong; Yanxia Zhang; Weihong Gong; Zhongyao Jia; Li Yan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.